FDA Inspection 864912 — Carter BloodCare - Irving

Carter BloodCare - Irving — FEI 3003103575

The FDA completed an inspection of Carter BloodCare - Irving on February 5, 2014 in Irving, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 5, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Irving, TX (United States)